Por favor, use este identificador para citar o enlazar este ítem: http://ciatej.repositorioinstitucional.mx/jspui/handle/1023/900
Parkinson’s disease: an update on preclinical studies of induced pluripotent stem cells
Valeria Valadez Barba
Karen Jaqueline Juárez Navarro
Eduardo Padilla Camberos
NESTOR FABIAN DIAZ MARTINEZ
JOSE RAUL GUERRA MORA
NESTOR EMMANUEL DIAZ MARTINEZ
Acceso Abierto
Atribución-NoComercial-SinDerivadas
https://doi.org/10.1016/j.nrleng.2023.10.004
"Parkinson’s disease (PD) is the second most prevalent neurodegenerative disease among adults worldwide. It is characterised by the death of dopaminergic neurons in the substantia nigra pars compacta and, in some cases, presence of intracytoplasmic inclusions of α-synuclein, called Lewy bodies, a pathognomonic sign of the disease. Clinical diagnosis of PD is based on the presence of motor alterations. The treatments currently available have no neuroprotective effect. The exact causes of PD are poorly understood. Therefore, more precise preclinical models have been developed in recent years that use induced pluripotent stem cells (iPSC). In vitro studies can provide new information on PD pathogenesis and may help to identify new therapeutic targets or to develop new drugs".
Elsevier España, S.L.U.
2023
Artículo
Neurología 38 (2023) 681—694
Inglés
Bibliotecarios
Empresas
Estudiantes
Investigadores
V. Valadez-Barba, K. Juárez-Navarro, E. Padilla-Camberos, N.F. Díaz, J.R. Guerra-Mora, N.E. Díaz-Martínez, Parkinson’s disease: an update on preclinical studies of induced pluripotent stem cells, Neurología (English Edition), Volume 38, Issue 9, 2023, Pages 681-694, ISSN 2173-5808, https://doi.org/10.1016/j.nrleng.2023.10.004.
CIENCIAS AGROPECUARIAS Y BIOTECNOLOGÍA
Versión publicada
publishedVersion - Versión publicada
Aparece en las colecciones: ARTICULOS

Cargar archivos:


Fichero Tamaño Formato  
202 Parkinson’s disease.pdf555.25 kBAdobe PDFVisualizar/Abrir